Market Place
Sourcing Support
Shionogi Presents Real-World Evidence Study Of Cefiderocol At IDWeek
16 Oct 2024 //
BUSINESSWIRE
ESCMID 2024: Shionogi Presents Fetcroja Real-World Efficacy Data
18 Apr 2024 //
BUSINESSWIRE
Shionogi Presents Evidence Demonstrating Effectiveness of Fetroja
11 Oct 2023 //
BUSINESSWIRE
Shionogi Announces Real-World Evidence Demonstrating the Efficacy of Fetcroja
17 Apr 2023 //
BUSINESSWIRE
Shionogi’s Antibiotic, FETCROJA Is Now Available in the Netherlands
22 Feb 2023 //
BUSINESSWIRE
Shionogi’s Innovative Antibiotic, FETCROJA, Is Now Available in Denmark
01 Feb 2023 //
BUSINESSWIRE
Shionogi’s Innovative Antibiotic, FETCROJA, Is Now Available in Norway
17 Jan 2023 //
BUSINESSWIRE
Shionogi Presents Real-World Evidence Showing Strong Efficacy with Fetroja
19 Oct 2022 //
BUSINESSWIRE
Shionogi’s novel antibiotic added to UK’s pilot subscription reimbursement model
23 Dec 2020 //
PHARMATIMES
Shionogi’s novel antibiotic added to UK’s pilot subscription reimbursement model
23 Dec 2020 //
PHARMATIMES
Shionogi`s novel antibiotic selected for UK pilot subscription model
21 Dec 2020 //
PHARMAFILE
Shionogi to Present New Data on FETROJA® (cefiderocol) at IDWeek 2020
19 Oct 2020 //
BUSINESSWIRE
FDA Approvals Roundup: Nucala, Fetroja, Xeljanz
30 Sep 2020 //
RAPS
Shionogi launches novel antibiotic Fetcroja in the UK
15 Sep 2020 //
PHARMATIMES
Shionogi Granted New Technology Add-on Payment For FETROJAÂ (Cefiderocol) by CMS
03 Sep 2020 //
BUSINESSWIRE
Shionogi Granted New Technology Add-on Payment For FETROJAÂ (Cefiderocol) by CMS
03 Sep 2020 //
BUSINESSWIRE
Fetroja Gets FDA’s Priority Review for Nosocomial Pneumonia
04 Jun 2020 //
JIHO
FDA Accepts Shionogi’s sNDA with Priority Review for FETROJA®
01 Jun 2020 //
BUSINESSWIRE
Shionogi Fetcroja (cefiderocol)Receives Approval in Europe
04 May 2020 //
EMA
EC approves Shionogi`s new antibiotic Fetcroja
27 Apr 2020 //
PHARMA TIMES
Shionogi Receives European Commission Marketing for FETCROJA® (cefiderocol)
27 Apr 2020 //
BUSINESSWIRE
Shionogi Receives Positive CHMP Opinion for FETCROJA® (cefiderocol)
02 Mar 2020 //
BUSINESSWIRE
CHMP Recommends One New Drug, Begins Review of Indian CRO
29 Feb 2020 //
RAPS
Shionogi’ introduces Fetroja in US market to treat complicated UTI
25 Feb 2020 //
PHARMABIZ
Shionogi receives FDA approval for cUTI drug
27 Nov 2019 //
BIOSPECTRUM ASIA
Despite worries triggered by imbalance of deaths
18 Oct 2019 //
ENDPTS
U.S. FDA Advisory Committee Recommends Approval of Cefiderocol
16 Oct 2019 //
BUSINESSWIRE
Shionogi`s APEKS-NP phase III trial of cefiderocol in patients
05 Oct 2019 //
PHARMABIZ
Shionogi to Present Data on Cefiderocol and Baloxavir Marboxil
27 Sep 2018 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.